Texas Health Steps providers should not use Magellan Diagnostics’ LeadCare analyzers for venous blood lead tests. The Centers for Disease Control and Prevention (CDC) issued a Health Advisory warning that the analyzers may underestimate blood lead levels and provide falsely low test results. The FDA recommends against using LeadCare analyzers for venous blood samples.
The safety alert does not apply to capillary blood lead test results collected by fingerstick or heelstick. Texas Health Steps providers may continue to use LeadCare II Analyzers for point-of-care blood lead screening when testing capillary samples.
Visit the CDC Health Advisory website for more information about the safety alert.